Sandra E. Fischer

12.0k total citations · 1 hit paper
146 papers, 5.6k citations indexed

About

Sandra E. Fischer is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Sandra E. Fischer has authored 146 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 45 papers in Hepatology and 42 papers in Surgery. Recurrent topics in Sandra E. Fischer's work include Liver Disease Diagnosis and Treatment (41 papers), Cancer Genomics and Diagnostics (23 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Sandra E. Fischer is often cited by papers focused on Liver Disease Diagnosis and Treatment (41 papers), Cancer Genomics and Diagnostics (23 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Sandra E. Fischer collaborates with scholars based in Canada, Germany and United States. Sandra E. Fischer's co-authors include Johane P. Allard, Ian D. McGilvray, Elena M. Comelli, Bianca M. Arendt, Scott Fung, Marialena Mouzaki, L. Sylvia, Maha Guindi, Thomas Clavel and Ilias Lagkouvardos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Sandra E. Fischer

132 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intestinal microbiota in patients with nonalcoholic fatty liver disease

2013 590 citations Marialena Mouzaki, Elena M. Comelli et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra E. Fischer Canada	35	2.1k	1.8k	1.4k	1.1k	817	146	5.6k
Javier Crespo Spain	39	3.7k 1.8×	1.4k 0.8×	2.3k 1.7×	932 0.9×	556 0.7×	365	7.1k
Jerry Polesel Italy	52	1.8k 0.9×	1.5k 0.8×	579 0.4×	1.1k 1.0×	636 0.8×	238	8.4k
Andrew L. Mason Canada	40	4.3k 2.0×	1.7k 1.0×	4.0k 2.9×	1.9k 1.8×	346 0.4×	158	7.8k
Alfredo Di Leo Italy	45	1.6k 0.8×	1.4k 0.8×	1.3k 1.0×	2.5k 2.3×	394 0.5×	308	6.9k
Xue Qin China	37	1.0k 0.5×	2.3k 1.3×	420 0.3×	696 0.6×	472 0.6×	348	6.3k
Francesco Paolo Schena Italy	64	1.2k 0.6×	2.8k 1.5×	580 0.4×	2.2k 2.0×	549 0.7×	279	14.1k
Masanori Abe Japan	43	3.1k 1.5×	751 0.4×	2.4k 1.8×	995 0.9×	559 0.7×	307	6.3k
Luca Miele Italy	40	4.4k 2.1×	1.8k 1.0×	1.5k 1.1×	961 0.9×	1.3k 1.6×	193	6.7k
Gerald Y. Minuk Canada	37	2.6k 1.3×	719 0.4×	2.7k 2.0×	969 0.9×	272 0.3×	222	4.8k
Luís Bujanda Spain	52	1.5k 0.7×	2.8k 1.6×	626 0.5×	3.4k 3.1×	609 0.7×	330	9.6k

Countries citing papers authored by Sandra E. Fischer

Since Specialization

Citations

This map shows the geographic impact of Sandra E. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra E. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra E. Fischer more than expected).

Fields of papers citing papers by Sandra E. Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra E. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra E. Fischer. The network helps show where Sandra E. Fischer may publish in the future.

Co-authorship network of co-authors of Sandra E. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra E. Fischer. A scholar is included among the top collaborators of Sandra E. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra E. Fischer. Sandra E. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Schwenger, Katherine J. P., Julia K. Copeland, Elena M. Comelli, et al.. (2025). Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters. Microbiome. 13(1). 9–9. 4 indexed citations

2.

Namdar, Khashayar, S. Carey, Sandra E. Fischer, et al.. (2025). Non-invasive liver fibrosis screening on CT images using radiomics. BMC Medical Imaging. 25(1). 285–285. 1 indexed citations

3.

Schwenger, Katherine J. P., Lina Chen, Anna Christina Tyler, et al.. (2024). Links between fecal microplastics and parameters related to metabolic dysfunction-associated steatotic liver disease (MASLD) in humans: An exploratory study. The Science of The Total Environment. 953. 176153–176153. 9 indexed citations

4.

Salvatore, Lisa, Yangqing Deng, Faiyaz Notta, et al.. (2024). GATA6 expression in advanced pancreatic ductal adenocarcinoma (PDAC) as a prognostic and predictive biomarker in the Canadian COMPASS trial and the Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.. Journal of Clinical Oncology. 42(16_suppl). 4150–4150.

5.

Knox, Jennifer J., Elizabeth M. Jaffee, Grainne M. O’Kane, et al.. (2024). Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01.. Journal of Clinical Oncology. 42(17_suppl). LBA4004–LBA4004. 6 indexed citations

6.

Schwenger, Katherine J. P., et al.. (2024). Assessing clinical and metabolic responses related to hyperlipidemia, MASLD and type 2 diabetes: sleeve versus RYGB. Nutrition. 126. 112530–112530. 2 indexed citations

7.

Fischer, Sandra E., et al.. (2023). Automated peak detection for analysis of error propagations and validation of structure functions in reliability tests of LED systems. 14. 1–7.

8.

Jhaveri, Kartik, Ali Babaei Jandaghi, Rajesh Bhayana, et al.. (2023). Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation. Cancer Imaging. 23(1). 22–22. 2 indexed citations

9.

Odedra, Devang, Ali Babaei Jandaghi, Rajesh Bhayana, et al.. (2022). Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation. Cancer Imaging. 22(1). 55–55. 2 indexed citations

10.

Chen, Xuchun, Xue‐Zhong Ma, Justin Manuel, et al.. (2020). Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation. Journal of Visualized Experiments. 1 indexed citations

11.

Chen, Xuchun, Xue‐Zhong Ma, Justin Manuel, et al.. (2020). Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation. Journal of Visualized Experiments. 3 indexed citations

12.

Naujock, Maximilian, et al.. (2020). Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity. Stem Cells and Development. 29(24). 1577–1587. 10 indexed citations

13.

Naujock, Maximilian, Sandra E. Fischer, Stefan Jäger, et al.. (2019). CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells. Molecular Neurobiology. 57(2). 616–634. 18 indexed citations

14.

Fischer, Sandra E., et al.. (2019). Multielectrode Array (MEA)-Based Detection of Spontaneous Network Activity in Human iPSC-Derived Cortical Neurons. Methods in molecular biology. 1994. 209–216. 6 indexed citations

15.

Eikenaar, Cas, et al.. (2019). An exception to the rule: Captivity does not stress wild migrating northern wheatears. General and Comparative Endocrinology. 275. 25–29. 10 indexed citations

16.

Lechner, Katharina, WU Li-ya, Elisa Waldmann, et al.. (2018). A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial. Nutrients. 10(2). 244–244. 101 indexed citations

17.

Mouzaki, Marialena, Elena M. Comelli, Bianca M. Arendt, et al.. (2013). Intestinal Microbiota in Patients with Non-Alcoholic Fatty Liver Disease. Hepatology. 7 indexed citations

18.

Reif, Jochen C., Wenxin Liu, Manje Gowda, et al.. (2010). Genetic basis of agronomically important traits in sugar beet (Beta vulgaris L.) investigated with joint linkage association mapping. Theoretical and Applied Genetics. 121(8). 1489–1499. 25 indexed citations

19.

Fischer, Sandra E. & L. Sylvia. (2008). Application of immunohistochemistry to thyroid neoplasms.. Archives of Pathology & Laboratory Medicine. 132(3). 359–372. 86 indexed citations

20.

Fischer, Sandra E., David Hopkinson, Stephen D. Cassivi, Stefano Saad, & A. Paul. (2000). Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. Transplantation Proceedings. 32(8). 2817–2819. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact